H₂-Receptor Antagonists in the Treatment of Reflux Oesophagitis

References

• Helm J F. Oesophageal acid clearance. J Clin Gastroenterol 1986; 8: 5–11
   PubMed Web of Science ®Google Scholar
• De Meester T R, Johnson L F, Joseph G J, Toscano M S, Hall A W, Skinner D B. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976; 1984: 459–469
   Google Scholar
• Johansson K E, Tibbling L. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment. Scand J Gastroenterol 1986; 21: 482–492
   Google Scholar
• Mittal R K, Reuben A, Whitney J O, McCallum R W. Do bile acids reflux into the esophagus? A study in normal subjects and patients with gastroesophageal reflux disease. Gastroenterology 1987; 92: 371–375
   PubMedGoogle Scholar
• Atkinson M, van Gelder A. Oesophageal intraluminal pH recording in the assessment of gastroesophageal reflux and its consequences. Dig Dis Sci 1977; 22: 365–370
   Web of Science ®Google Scholar
• Johnson L F, Demeester T R, Haggitt R C. Oesophageal epithelial response to gastroesophageal reflux. A quantitative study. Dig Dis Sci 1978; 23: 498–509
   Web of Science ®Google Scholar
• Richter J E, Castell D O. Gastroesophageal reflux. Pathogenesis, diagnosis and therapy. Ann Intern Med 1982; 97: 93–103
   PubMed Web of Science ®Google Scholar
• De Caestaker J S, Blackwell J N, Pryde A, Heading R C. Daytime gastroesophageal reflux is important in oesophagitis. Gut 1987; 28: 519–526
   PubMedGoogle Scholar
• Schindlbeck N E, Heinrich C, Konig A, Dendorfer A, Pace F, Muller-Lissner S A. Optimal thresholds, sensitivity and specificity of long-term pH-metry for the detection of gastrosophageal reflux disease. Gastroenterology 1987; 93: 85–90
   PubMed Web of Science ®Google Scholar
• Klauser A G, Heinrich C, Schindbeck N E, Muller-Lissner S A. Is long-term oesophageal pH monitoring of clinical value?. Am J Gastroenterol 1989; 84: 362–366
   PubMed Web of Science ®Google Scholar
• Robertson D AF, Aldersely M A, Shepherd H, Lloyd R S, Smith C L. H2-antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?. Gut 1987; 28: 946–949
   PubMed Web of Science ®Google Scholar
• Bennett J R, Martin H D, Buckton G. Cimetidine in gastroesophageal reflux. Digestion 1983; 26: 166–172
   PubMed Web of Science ®Google Scholar
• Aprill N, Eckrich J, Wang C, Klemenschitsch P, De Meester T R, Winans C. Quantitative reduction of gastroesophageal acid reflux by cimetidine. Gastroenterology 1979; 76: 1092(A)
   Google Scholar
• Deschalliers J P, Galmiche J P, Touchais J Y, Denis P, Colin R. Ranitidine, cimetidine, antacids and gastroesophageal reflux: results of a 20-hour oesophageal pH study. Int J Pharm Res 1984; 4: 217–222
   Google Scholar
• Klinkenberg-Knol E C, Festen H PM, Meuwissen S GM. Omeprazole compared to ranitidine in effect on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis. Gastroenterology 1987; 92: 1471, (A)
   Google Scholar
• Weiser H F, Gubernatis G, Siewert J R. Einfluss von Oxmetidin und Ranitidin auf das Reflux Verhalten von Patienten mit Esophagitis. Z Gastroenterol 1983; 21: 580–584
   PubMedGoogle Scholar
• Orr W C, Robinson M G, Humphries T J, Antonello J, Cagliola A. Dose response effects of famotidine on gastroesophageal reflux (GER). Gastroenterology 1987; 92: 1562, (A)
   Google Scholar
• Sangaletti O, Pace F, Bianchi Porro G. Gastroesophageal reflux in patients with esophagitis ‘resistant’ to H2-antagonsists. Gastroenterology 1989; 96: 439, (A)
   Google Scholar
• Collen M J, Ciarleglio C A, Stanczak V J, Benjamin S B. Oesophageal pH monitoring, gastric acid output and gastric volume output in patients with GERD unresponsive to standard antisecretory therapy. Gastroenterology 1987; 92: 1442, (A)
   Google Scholar
• Jansen J BMJ, Baak L C, Lamers C BHW. Are increasing doses of ranitidine helpful in reducing acid exposure of the oesophagus in reflux oesophagitis?. Proceedings of the Dutch Society of Gastroenterology. October, 1988
   Google Scholar
• Schaub N, Meyrick Thomas J, Misiewicz J J, Lovell D, Trotman I F. Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease. Hepatogastroenterol 1986; 33: 208–213
   PubMedGoogle Scholar
• Meuwissen S GM, Klinkenberg-Knol E C. Treatment of reflux oesophagitis with H2-receptor antagonists. Scand J Gastroenterol 1988; 23(suppl 146)201–213
   Google Scholar
• Koelz H R. Treatment of reflux oesophagitis with Hi-blockers, antacids and prokinetic drugs: an analysis of randomised clinical trials. Scand J Gastroenterol 1989; 24(suppl 156)25–36
   Google Scholar
• Stalnikowicz-Darvasi R. H2-antagonists in the treatment of reflux oesophagitis: a critical analysis. Am J Gastroenterol 1989; 83: 245–248
   Google Scholar
• Kaul B, Petersen H, Ericksen H, et al. Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine. Scand J Gastroenterol 1986; 21: 139–145
   PubMed Web of Science ®Google Scholar
• Wesdorp I CE (1982) Review of the use of ranitidine in reflux oesophagitis. Ranitidine. Proceedings of an international symposium held in the context of the Seventh World Congress of Gastroenterology Stockholm. June, 1982, A J Riley, P R Salmon. Excerpta Medica, Amsterdam, 95–101
   Google Scholar
• Bovero E, Cheli R, Barbara L, et al. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study. Hepatogastroenterol 1987; 34: 155–159
   PubMedGoogle Scholar
• Rohner H G, Wienbeck M. Zwei oder eine Tagesdosis Ranitidin zur Behandlung der Refluxosophagitis?. Z Gastroenterol 1986; 24: 396–402
   PubMedGoogle Scholar
• Halvorsen L, Lee F I, Wesdorp I CE, Johnson N J, Mills J G, Wood J R. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with ranitidine 300 mg at bedtime. Aliment Pharmacol Therap 1989; 3: 171–182
   PubMed Web of Science ®Google Scholar
• Harvey R F, Hadley N, Gill T R, et al. Effects of sleeping with bed head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 1988; 2: 1200–1203
   Google Scholar
• Fielding J F, Doyle G B. Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis. In Med J 1984; 77: 356–357
   Google Scholar
• Kimmig J M. Cimetidin und Ranitidin in der Behandlung der Refluxosophagitis. Z Gastroenterol 1984; 22: 373–378
   PubMed Web of Science ®Google Scholar
• Gonzalez J C, Da Silva N, Diaz D, et al. Cimetidine vs ranitidine in the treatment of reflux oesophagitis. DigDisSci 1986; 31: 467S, (A)
   Google Scholar
• Brunner G, Losgen H, Harke U. Ranitidine in the treatment of cimetidine resistant ulceration of the upper gastrointestinal tract. Therapiewoche 1982; 32: 4154–4158
   Google Scholar
• Berges W, Lux G, Simon B, Wienbeck M, Quik R. A comparison of two doses of nizatidine in reflux oesophagitis. Z Gastroenterol 1989; 27: 156, (A)
   Google Scholar
• Cooper M J, Hentschel E, Schutze K, Quik R FP. A comparison of the safety and efficacy of nizatidine versus placebo in the treatment of reflux oesophagitis. Z Gastroenterol 1989; 27: 162
   Google Scholar
• Weinbeck M, Rohner H G, Huttemann W, Belz W. Etintidin versus ranitidin in der Behandlung der Refluxosophagitis. Dtsch Med Wochenschr 1986; 111: 1501–1502
   PubMedGoogle Scholar
• Berlin R, Ebel D, Cook T. Famotidine (F) 40 HS vs Ranitidine (R) in the treatment of reflux oesophagitis: the results of a multicentre trial. Gastroenterology 1989; 96: A39
   Google Scholar
• Ayres R CS, Ryan L, Robertson D AF, Smith C L. Treatment failure with H2-receptor antagonists in reflux oesophagitis is due to diminished suppression of gastric acid secretion. Gastroenterology 1989; 96: 20, (A)
   Google Scholar
• Bianchi Porro G, Pace F, Lazzaroni M. Oesophagitis healing with ranitidine. Gastroenterology 1987; 92: 2051–2052
   PubMed Web of Science ®Google Scholar
• Johnson N J, Boyd E JS, Mills J G, Wood J R. Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Ther 1989; 3: 259–266
   PubMed Web of Science ®Google Scholar
• Cloud M, Offen W. Nizatidine 150 mg bid relieves symptoms and decreases severity of oesophagitis in gastroesophageal reflux disease. Gastroenterology 1989; 96: 91
   Google Scholar
• Frank W O, Wetherington J, Palmer R H, Young M D. Cimetidine–effect therapy for reflux oesophagitis (RE). Gastroenterology 1989; 96: 156
   Google Scholar
• Wesdorp I CE, Bartelsman J FWM, Schipper M EI, Tytgat G N. Effects of long-term treatment with cimetidine and antacids in Barrett's oesophagus. Gut 1981; 22: 724–727
   PubMed Web of Science ®Google Scholar
• Humphries T J. Effects of long-term medical therapy with cimetidine and bethanecol in patients with esophagitis and Barrett's oesophagus. J Clin Gastroenterol 1987; 9: 28–32
   PubMedGoogle Scholar
• Andersson R, Loewgren B. Ranitidine therapy of Barrett's ulcer. Case report. Acta Chir Scand 1986; 152: 629–631
   PubMedGoogle Scholar
• Hameetman W, Tytgat G TN. Healing of chronic Barrett's ulcer with omeprazole. Am J Gastroenterol 1986; 81: 764–766
   PubMedGoogle Scholar
• Patel G K, Clift S A, Schaefer R A, Read R C, Texter E C. Resolution of severe dysplastic (Ca in situ) changes with regression of columnar epithelium (CE) in Barrett's oesophagus on medical treatment (MT). Gastroenterol 1982; 82: 1147, (A)
   Google Scholar
• Lieberman D A. Medical therapy for chronic reflux oesophagitis. Long-term follow-up. Arch Intern Med 1987; 147: 1717–1780
   PubMedGoogle Scholar
• Little A G, Matinez E I, De Meester T R, Blough R M, Skinner D B. Duodenogastric reflux and reflux oesophagitis. Surgery 1984; 96: 447–454
   PubMedGoogle Scholar
• McCallum R W, Fink S M, Lerner E, Berkowitz D M. Effects of metoclopramide and bethanecol on delayed gastric emptying in gastroesophageal reflux patients. Gastroenterol 1983; 84: 1573–1577
   PubMed Web of Science ®Google Scholar
• Temple J G, Bradby G V, O'Connor F O, et al. Cimetidine and metoclopramide in oesophageal reflux disease. Br Med J 1983; 286: 1863–1864
   PubMed Web of Science ®Google Scholar
• Lieberman D A, Keefe E B. Treatment of severe reflux oesophagitis with cimetidine and metoclopramide. Ann Intern Med 1986; 104: 21–26
   PubMed Web of Science ®Google Scholar
• Masci E, Testoni P A, Passaretti S, Guslandi M, Titobello A. Comparison of ranitidine, dom-peridone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis. Drugs Exp Clin Res 1985; 11: 687–692
   PubMedGoogle Scholar
• Wienbeck M. Therapeutic effect of cisapride added on to ranitidine in patients with reflux oesophagitis. Dig Dis Sci 1986; 31(suppl 110)97, (A)
   Google Scholar
• Galmiche J P, Brandstatter G, Evereux M, et al. Benefit of combined treatment with cisapride and cimetidine in the treatment of severe reflux oesophagitis: a placebo-controlled trial. Gut 1988; 29: 675–681
   PubMed Web of Science ®Google Scholar
• Hameetman W, Schotborgh R H, van der Boomgaard D M, et al. Combination therapy of sucralfate and cimetidine compared with sucralfate monotherapy in patients with reflux esophagitis. Z Gastroenterol 1989; 27: 169–170, (A)
   Google Scholar
• Herrera J L, Shay S S, McCabe M, Peura D A, Johnson L F. Sucralfate used as adjunctive therapy in patients with severe erosive peptic oesophagitis: a randomised double-blind controlled trial. Gastroenterol 1989; 96: 207, (A)
   Google Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux oesophagitis. Results of a double-blind, randomised Scandinavian multicentre study. Scand J Gastroenterol 1988; 23: 625–632
   PubMed Web of Science ®Google Scholar
• Festein H PM, Driessen W MM, Lamers C BH, Van Tongeren J HM. Cimetidine in the treatment of severe ulcerative reflux oesophagitis: results of an 8-week double-blind study and of subsequent long-term treatment. Neth J Med 1980; 23: 237–240
   PubMedGoogle Scholar
• Bright-Asare P, Behar J, Brand D L. Effect of long-term maintenance cimetidine (CIM) therapy on gastroesophageal reflux disease (GERD). Gastroenterol 1982; 82: 1025
   Web of Science ®Google Scholar
• Koelz H R, Birchler R, Bretholz A, et al. Healing and relapse of reflux oesophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• Scherbaniuk R, Wensel R, Bailey R, et al. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease. J Clin Gastroenterol 1984; 6: 9–15
   PubMedGoogle Scholar
• McCallum R W, Sontag S J, Vlahcevic Z R, et al. Ranitidine versus placebo in long-term treatment of gastroesophageal reflux. Am J Gastroenterol 1985; 80: 864, (A)
   Google Scholar
• Hendel L, Aggestrup S, Stenthoft P. Long-term ranitidine in progressive systemic sclerosis (scleroderma) with gastroesophageal reflux. Scand J Gastroenterol 1986; 21: 799–805
   PubMed Web of Science ®Google Scholar
• Berlin R, Ebel D, Cook T. Famotidine (F) 20 HS & 40 HS vs placebo in the maintenance therapy (MT) of reflux oesophagitis (RE): results of a double-blind multi-centre trial. Gastroenterology 1989; 96: 39, (A)
   Google Scholar
• Ferguson R, Dronfield M W, Atkinson M. Cimetidine in the treatment of reflux oesophagitis with peptic strictures. Br Med J 1977; 2: 472–474
   Google Scholar
• Starlinger M, Appel W H, Schemper M, Schiessel R. Long-term treatment of peptic oesophageal stenosis with dilatation and cimetidine: factors influencing the clinical result. Eur Surg Res 1985; 17: 207–214
   PubMedGoogle Scholar
• Petrokubi R J, Jefferies G H. Cimetidine versus antacid in scleroderma with reflux oesophagitis. A randomised double-blind controlled study. Gastroenterology 1979; 77: 691–695
   PubMed Web of Science ®Google Scholar
• Lamers C BHW. Treatment of peptic ulcer disease. Glaxo Publ., Nieuwegein 1985
   Google Scholar
• Lamers C BHW, Disselhoff R ML. Advances in gastroenterology. Glaxo Publ., Nieuwegein 1987
   Google Scholar
• Lamers C BHW, Disselhoff R ML. Highlights of gastroenterology in The Netherlands, 1988. Scand J Gastroenterol 1988; 23(suppl 154)
   PubMedGoogle Scholar